Gastroesophageal reflux disease (GERD) is a chronic digestive disorder that affects the lower esophageal sphincter (LES), the ring of muscle between the stomach and esophagus. It occurs when acidic stomach juices, or food and fluids flow back up into the food pipe (esophagus). The backwash irritates the lining of the esophagus and causes GERD. It affects all ages from infants to older adults. The symptoms of GERD include difficulty while swallowing (dysphagia), heartburn sensation, regurgitation or acid reflux, dry cough, sore throat, and chest pain. Scope of the Report: This report studies the GERD market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the GERD market by product type and applications/end industries. The antacids segment to account for more than 58% of the total market share during the forecast period. This segment consists of drugs that contain weak bases. These bases react with stomach acids to neutralize and release salt and water. The oral route of drug administration to be the most preferred route of drug administration during the forecast period. The drugs administered through this route have to undergo first-pass metabolism and can be administered as tablets, capsules, and oral liquids. This route?s high degree of safety will result in its augmented preference during the forecast period. The global GERD market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of GERD. Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%. Market Segment by Companies, this report covers AstraZeneca Eisai GlaxoSmithKline Johnson & Johnson Takeda CJ Cheil Jedang Daewoong Pharmaceutical SFJ Pharmaceuticals Group Vecta Pharmaceuticals Zeria Pharmaceuticals Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Proton Pumps Inhibitors H2 Receptor Antagonists Antacids Prokinetics Other Market Segment by Applications, can be divided into Hospital Pharmacies Retail Pharmacies Online Pharmacies
Table of Contents 1 GERD Market Overview 1.1 Product Overview and Scope of GERD 1.2 Classification of GERD by Types 1.2.1 Global GERD Revenue Comparison by Types (2017-2023) 1.2.2 Global GERD Revenue Market Share by Types in 2017 1.2.3 Proton Pumps Inhibitors 1.2.4 H2 Receptor Antagonists 1.2.5 Antacids 1.2.6 Prokinetics 1
